Model-Based Meta-Analysis of Objective Response Rate and Survival Endpoints to Compare PD-1 and PD-L1 Treatment Outcomes in Non-Small Cell Lung Cancer Publication Model-Based Meta-Analysis of Objective Response Rate and Survival Endpoints to Compare PD-1 and PD-L1 Treatment Outcomes in Non-Small Cell Lung Cancer This study used model-based meta-analysis (MBMA) to assess how well objective response rate (ORR) predicts…Danielle Pillsbury2026 年 3 月 4 日
Apotekarsocieteten Clinical Pharmacology Strategies in Drug Development Conference Apotekarsocieteten 临床药理学策略在药物开发中的应用 Danielle Pillsbury2026 年 3 月 2 日
Document Quality and Management Fact Sheet 文件质量和管理 Ensure submission readiness with Certara’s Document Quality services. We deliver compliant, inspection-ready regulatory documents that…Certara2026 年 2 月 27 日
Safety & Pharmacovigilance Writing Fact Sheet 安全性与药物警戒撰写 Expertly delivering Safety & Pharmacovigilance Writing services, including Aggregate Safety Reports, Risk Management Plans, and…Certara2026 年 2 月 27 日
博客 Rare Disease Day 2026: Accelerating Rare Disease Drug Development Through Cross-Functional Innovation On Rare Disease Day 2026, Certara experts share how cross-functional innovation, regulatory strategies for rare…Certara2026 年 2 月 26 日
Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance Press Release Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance FY 2025 Revenue of $418.8M (9% growth) and Adj. EBITDA of $134.5M (10% growth) Fourth…Certara2026 年 2 月 26 日
Guided by Evidence: Implementing the ICH M15 Guideline for Model-Informed Drug Development (MIDD) Guide Guided by Evidence: Implementing the ICH M15 Guideline for Model-Informed Drug Development (MIDD) Prepare for ICH M15 guideline: Learn how to assess model credibility, align terminology, and strengthen…Certara2026 年 2 月 13 日
EMA Policy 0070 Submission Readiness Checklist Guide EMA Policy 0070 Submission Readiness Checklist Use this EMA Policy 0070 Submission Checklist to prepare compliant clinical data packages, manage anonymization…Certara2026 年 2 月 12 日
Pediatric Drug Development: From “Wild West” to Model-Informed Confidence Blog Pediatric Drug Development: From “Wild West” to Model-Informed Confidence Model-informed drug development and precision dosing are transforming pediatric programs, from regulatory planning to Bayesian…Certara2026 年 2 月 11 日
Population Pharmacokinetics of Clesrovimab in Preterm and Full-Term Infants Publication Population Pharmacokinetics of Clesrovimab in Preterm and Full-Term Infants This study, published in Clinical Pharmacology & Therapeutics (CPT), shows how population pharmacokinetic modeling supports…Certara2026 年 2 月 2 日